Supreme Court Rejects ‘Pharma Bro’ Shkreli’s Appeal of $64.6 Million Penalty
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli’s challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug’s price by more than 4,000%. The justices turned …